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Abstract
Several conditions associated with reduced gastric acid secretion confer an altered risk of
developing a gastric malignancy. Helicobacter pylori-induced atrophic gastritis predisposes
to gastric adenocarcinoma, autoimmune atrophic gastritis is a precursor of type I gastric
neuroendocrine tumours, whereas proton pump inhibitor (PPI) use does not affect stomach
cancer risk. We hypothesised that each of these conditions was associated with specific
alterations in the gastric microbiota and that this influenced subsequent tumour risk. 95
patients (in groups representing normal stomach, PPI treated, H. pylori gastritis, H. pylori-
induced atrophic gastritis and autoimmune atrophic gastritis) were selected from a cohort of
1400. RNA extracted from gastric corpus biopsies was analysed using 16S rRNA sequenc-
ing (MiSeq). Samples from normal stomachs and patients treated with PPIs demonstrated
similarly high microbial diversity. Patients with autoimmune atrophic gastritis also exhibited
relatively high microbial diversity, but with samples dominated by Streptococcus. H. pylori
colonisation was associated with decreased microbial diversity and reduced complexity of
co-occurrence networks. H. pylori-induced atrophic gastritis resulted in lower bacterial abun-
dances and diversity, whereas autoimmune atrophic gastritis resulted in greater bacterial
abundance and equally high diversity compared to normal stomachs. Pathway analysis sug-
gested that glucose-6-phospahte1-dehydrogenase and D-lactate dehydrogenase were over
represented in H. pylori-induced atrophic gastritis versus autoimmune atrophic gastritis, and
that both these groups showed increases in fumarate reductase. Autoimmune and H. pylori-
induced atrophic gastritis were associated with different gastric microbial profiles. PPI
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treated patients showed relatively few alterations in the gastric microbiota compared to
healthy subjects.
Author summary
Different conditions such as autoimmune atrophic gastritis and Helicobacter pylori associ-
ated atrophic gastritis are associated with different types of gastric cancer, specifically neu-
roendocrine tumours and adenocarcinoma. Both conditions result in reduced gastric acid
secretion, potentially allowing non-H. pylori bacteria to colonise the stomach. However
patients receiving proton pump inhibitors (PPI) experience similar levels of acid secretion,
but do not develop gastric cancer. The aims of this study were to investigate the contribu-
tion of non-H. pylori microbiota to gastric tumour development in the presence of
reduced gastric acid secretion. 16S rRNA sequencing identified relatively few alterations
in the gastric microbiota in patients receiving PPI therapy, despite reduced acid secretion,
but more substantial alterations in those patents who had atrophic gastritis. Significant
differences were also found between the patients who had atrophic gastritis of autoim-
mune and H. pylori associated types. Differences in biochemical pathways that potentially
contribute to gastric tumorigenesis were also predicted. This work increases understand-
ing of the mechanisms involved in gastric tumour development, and demonstrates how
non-H. pylori bacteria may be important. This work may eventually lead to the develop-
ment of novel chemopreventive therapies for stomach cancer that are based on altering
the composition of the gastric microbiota.
Introduction
Gastric adenocarcinoma is the third most common cause of cancer related mortality world-
wide[1] and most cases are associated with chronic Helicobacter pylori infection. Gastric cancer
usually develops via the premalignant condition of gastric atrophy, which is associated with
the loss of acid-secreting parietal cells[2]. The resulting hypochlorhydria potentially leads to
alterations in the composition of the gastric microbiota by providing a more favourable envi-
ronment for colonisation. It is currently unclear to what extent the non-H. pylori gastric
microbiota contributes towards gastric carcinogenesis. Although the hypochlorhydria associ-
ated with autoimmune atrophic gastritis also increases the risk of developing gastric adenocar-
cinoma[3], it is more frequently associated with the development of another tumour, the type I
gastric neuroendocrine tumour (NET)[4]. However, hypochlorhydria does not always increase
the risk of gastric tumour development, as observed following chronic proton pump inhibitor
(PPI) use[5]. Therefore, factors in addition to hypochlorhydria affect gastric cancer risk and
one of these could be the gastric microbiota.
Although originally thought to be sterile, several bacterial communities have been shown to
survive in the normal human stomach[6]. Differences have also been observed depending
upon H. pylori status[6].There is now overwhelming evidence that certain bacteria influence
cancer development. Potential mechanisms include altering the host immune system, exacer-
bating inflammation, or converting dietary nitrates to produce carcinogens such as N-nitrosa-
mines and nitric oxide[7–13].
We therefore hypothesised that three stimuli which result in hypochlorhydria, namely H.
pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor
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use cause specific changes to the composition of the gastric microbiota. In addition, the gastric
microbiota that is present in these conditions contributes towards the specific gastric tumour
risk that is associated with each of these hypochlorhydric states. We have used 16S rRNA
sequencing to determine the gastric mucosal microbiota profiles in patients with these causes
of hypochlorhydria and have compared these with samples obtained from healthy subjects and
from patients with H. pylori-induced gastritis, but no evidence of gastric atrophy.
Results
Patient characteristics
Patients were selected from the larger cohort according to criteria defined in the methods sec-
tion and Table 1. Characteristics of the selected patients are shown in Table 1 and Fig 1A. One
sample from the normal stomach group and four from the PPI-treated group were subse-
quently excluded because sequencing showed the presence of>15% H. pylori despite this
organism being undetected by conventional clinical tests (most likely due to the higher sensi-
tivity of 16S rRNA sequencing compared to routine clinical tests). This is likely to be genuine
H. pylori carriage since technical controls were included in each sequencing run and these con-
trols showed lower diversity and levels of H. pylori than the samples (Figs 2 & 3). Ninety-five
samples were therefore analysed. Negative extracts from the RNA extraction procedures, a
water sample in the first PCR and a mock bacterial community were also sequenced.
Detection of Operational Taxonomic Units (OTUs)
In total 10,386 OTUs were identified. Extraction controls contained fewer OTUs than the
patient samples, whilst the mock communities showed consistency between MiSeq runs (Figs
1–3). Despite the negative extracts being theoretically sterile, as expected they generated 16S
signals due to known background reagent contamination[14]. Samples from the autoimmune
atrophic gastritis group contained the largest number of OTUs, whilst all other patient groups
were comparable (Fig 1B). Mock communities demonstrated the expected bacterial ratios (Fig
3B).
Table 1. Summary of patient group characteristics.
Group Total no.
of
samples
Number
of
females
Age (years) BMI H. pylori
serology
+ve
H. pylori
histology
/urease +ve
PPI
use
Atrophic
gastritis
Serum gastrin
(pM)
Anti GPC/
IF
antibodyMedian IQR Median IQR Median IQR
1 Normal 20 13 46 30.5–
58.7
24.5 21.2–
26.8
0 0 - - 22.5 17.5–
28.5
- or ND
2 PPI treated 19 13 60 46–
67
28.5 26.1–
33.2
0 0 + - 140 94–
200
- or ND
3 H. pylori
gastritis 22
11 57.5
47.7–
64
27.4
23.3–
27.1
22 22
-
- 21.5 17.4–
28
- or ND
4 H. pylori
atrophy 23
15 65
55–
72
25.9
24.6–
31.9
23 6
-
+ 100 64–
260
- or ND
5 Autoimmune
atrophy 11
6 67
60–
76
28.6
23.7–
35
2 0
-
+ 800 470–
1050
+
ND = Not done
IQR = Interquartile range, 25% and 75%
https://doi.org/10.1371/journal.ppat.1006653.t001
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Bacterial diversity and abundance in the different hypochlorhydric states
Twenty-three known phyla were identified, mainly Proteobacteria, Firmicutes, Bacteroidetes,
Actinobacteria, Fusobacteria and Cyanobacteria. Bacteroidetes, followed by Proteobacteria
and Firmicutes were most common in normal stomachs, whereas samples from PPI-treated
patients contained slightly more Firmicutes and fewer Bacteroidetes. The H. pylori gastritis
and H. pylori atrophic gastritis samples were dominated by Proteobacteria (as Helicobacter
itself is a member of this phylum), whilst biopsies from patients with autoimmune atrophic
gastritis contained the largest proportion of Firmicutes compared to all other patient groups.
Alpha diversity. Diversity indices demonstrated that the microbiota in normal stomachs
was significantly more diverse than in the stomachs of all other patient groups except for the
patients who had autoimmune atrophic gastritis (Fig 2, all panels). Evaluation of evenness (by
Pielou’s evenness and Simpson) suggested that the samples from normal stomachs and from
the stomachs of patients taking PPIs contained bacterial communities that were more equal in
abundance than those in the other patient groups, which were more skewed (Fig 2). Calcula-
tions based on richness indicated that the samples from normal stomachs also contained the
greatest number of different bacterial species compared to all other groups, whilst the two H.
pylori infected groups (H. pylori-induced gastritis and atrophy) contained significantly fewer
species.
Beta diversity. When beta diversity was explored using nonmetric distance scaling
(NMDS), patient groups clustered predominantly by bacterial abundance (Fig 4). When H.
pylori was removed from the analysis however, H. pylori gastritis patients no longer clustered
separately by abundance from subjects with normal stomachs (Fig 4). Despite this, following
removal of H. pylori, there was a significant difference in abundance for H. pylori-induced
atrophic gastritis patients compared to normal stomachs, suggesting strongly that there are dif-
ferences in the proportions of non-H. pylori bacteria in these subjects compared with others
(Fig 4). Samples from patients who had autoimmune atrophic gastritis displayed the only sig-
nificant differences in terms of the presence or absence of specific bacteria compared to other
groups (Fig 4). This suggests that changes in the gastric bacterial community during hypo-
chlorhydria usually involve changes in the relative proportions of bacteria that are already
present, and only rarely involve the loss or gain of specific bacterial genera.
Fig 1. (A) Median fasting serum gastrin concentrations (pM) in patient groups. Kruskal-Wallis test with
Dunn’s comparison, plotted using Tukey’s method * = P<0.05, and **** = P<0.0001 vs control. (B) Mean
number of OTUs identified within each patient group, 1-way ANOVA and Tukey’s multiple comparison test * =
P<0.05, ** = P<0.01, Control vs Autoimmune atrophic gastritis P = 0.059, Control vs Neg P = 0.061 and Hp-
induced atrophic gastritis vs Neg P = 0.059.
https://doi.org/10.1371/journal.ppat.1006653.g001
Comparison of the human gastric microbiota in hypochlorhydric states
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006653 November 2, 2017 4 / 18
Comparisons between the microbiota profiles in the different patient
groups and healthy controls
Normal stomach versus PPI treated patients. Patients receiving PPIs showed similar
bacterial profiles to those found in the stomachs of normal subjects, despite having signifi-
cantly higher serum gastrin concentrations (suggesting the presence of hypochlorhydria) (Figs
1A, 3 & S1). Nonetheless there were differences in the ranks of most abundant bacterial fami-
lies. In normal (control) patients Prevotellaceae were the most abundant bacterial family
(23%), followed by Streptococcaceae (10%), Paraprevotellaceae (7%) and Fusobacteriaceae
(5%); amongst PPI-treated individuals Streptococcaceae (17%) outranked Prevotellaceae
(11%), Campylobacteraceae (5%) and Leptotrichiaceae (4%; Fig 3A). The only significant dif-
ferences at genus level between these groups were decreases in Actinobacillus and Tannerella
in the PPI-treated stomachs (S1 Table). At the OTU level, Cyanobacteria, and Streptococcus
were significantly increased in the PPI-treated samples, whereas Prevotella, Porphyromonas,
Treponema, Leptotrichiaceae, Haemophilus, and Fusobacterium were significantly decreased
compared to normal stomachs (S2 Fig).
Very few differences were identified in co-occurrence network analyses when the micro-
biota in normal stomachs was compared to PPI-treated stomachs. The only observed differ-
ence was a negative correlation between Helicobacter and Acinetobacter in the PPI-treated
samples, whereas this relationship was positively correlated in normal stomach biopsies (Fig
5A and S3A & S2A Tables). Predicted pathway analysis showed no significantly different bio-
chemical pathways between these two groups (S3 Table).
Fig 2. Five different diversity indices of human gastric microbiota (Fisher alpha: parametric index of diversity that models species as logseries
distribution; Pielou’s evenness: how close in numbers each species is; Richness: number of species per sample; Shannon: a commonly used
index to characterise species diversity; and Simpson: which takes into account the number of species present, as well as their relative
abundance). Pair-wise ANOVA was performed between different groups and if significant (P<0.001), the p-values have been drawn on top. HP atrophy = H.
pylori associated atrophy, Auto atrophy = autoimmune atrophic gastritis, Control = normal stomach, HP gastritis = H. pylori associated gastritis, PPI = proton
pump inhibitor and negative = extraction control.
https://doi.org/10.1371/journal.ppat.1006653.g002
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Normal stomach versus H. pylori-induced gastritis. Unsurprisingly, the microbiota in
the stomachs of patients who had H. pylori-induced gastritis consisted almost entirely of Heli-
cobacteraceae (97%) (Fig 3). When compared to normal patients, H. pylori-induced gastritis
patients showed a greater number of differences at the genus level than all other patient groups
(S1 Table). The majority of these differences resulted from reductions in the proportions of
several bacterial genera within the H. pylori gastritis group. To ensure that the dominance of
H. pylori did not skew the proportions of the other bacteria in a misrepresentational way, H.
pylori OTUs were removed from the abundance table followed by differential expression analysis
on the remaining raw abundances. This analysis resulted in almost identical results to when H.
pylori remained (S1 Table). Due to the dominance of H. pylori in these patients, very few co-
occurrence networks were identified, but positive correlations were observed between Kocuria
and Skermanella in both groups (Fig 5A & 5B). Predicted pathway analysis suggested a reduction
in several dehydrogenases in the stomachs of patients who had H. pylori gastritis (S3 Table).
Normal stomach versus H. pylori-induced atrophic gastritis. The stomachs of patients
who had H. pylori-induced atrophic gastritis were also dominated by Helicobacteraceae (62%),
followed by Streptococcaceae (5%), Fusobacteriaceae (2%) and Prevotellaceae (2%) (Fig 3). At the
Fig 3. Relative abundances of taxa found within (A) groups and (B) individual human gastric biopsies. Hp = H. pylori, IM = intestinal metaplasia, IM
+At = intestinal metaplasia and atrophy, PPI = proton pump inhibitor, EC = extraction controls (one of the EC samples was included in a run with more H.
pylori dominant samples), H = H2O and M = mock community (which showed consistent findings on two runs as shown). All H. pylori atrophic gastritis
samples were positive for H. pylori by serology, + indicates whether these samples were also positive by histology/rapid urease test. Autoimmune atrophic
gastritis samples recorded as ‘s’ were also positive for H. pylori by serology.
https://doi.org/10.1371/journal.ppat.1006653.g003
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genus level, several differences were observed between normal stomachs and the stomachs of
patients with H. pylori-induced atrophic gastritis. These included decreases in the proportions of
Fig 4. Nonmetric distance scaling (NMDS) demonstrating clustering of patient groups using (A) unweighted Unifrac distance (pair-wise distance between
samples is calculated as a normalised difference in cumulative branch lengths of the observed OTUs for each sample on the phylogenetic tree without taking
into account their abundances in samples), (B) Bray-Curtis distance (abundance of OTUs alone and not considering the phylogenetic distance) and (C)
weighted Unifrac (unweighted unifrac distance weighted by abundances of OTUs). Serum gastrin concentration indicated by size of each point. Ellipses
represent 95% CI of standard error for a given group. Dotted ellipses represent the 95% CI of standard error when H. pylori were removed from the analysis.
Atrophy = H. pylori associated atrophic gastritis, Auto = autoimmune atrophic gastritis, Control = normal, HP Gastr = H. pylori associated gastritis and
PPI = proton pump inhibitor. PERMANOVA (distances against groups) suggests significant differences (P<0.001 for all three distances) in microbial
community explaining the following variations (R2) between groups: 10% (8.6% without H. pylori when using Unweighted Unifrac; 58% (14.5% without H.
pylori) when using Weighted Unifrac; and 15% when using Bray-Curtis distance. No significant explanation was observed (P>0.05) for age, BMI, or serum
gastrin concentration in the PERMANOVA test. (D) Data from betadisper plots (a mean to compare the spread/variability of samples for different groups)
representing difference in distances (Bray-Curtis, Unweighted and weighted Unifrac) of group members from the centre/mean of individual groups after
obtaining a reduced-order representation of abundance table using Principle Coordinate Analysis. The pair-wise differences in distances from group centre/
mean were then subjected to ANOVA and if significant (P<0.001), the p-values were drawn on top.
https://doi.org/10.1371/journal.ppat.1006653.g004
Comparison of the human gastric microbiota in hypochlorhydric states
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006653 November 2, 2017 7 / 18
Fig 5. Co-occurrence network analysis between different genera (OTUs collated together at genus level) when considering samples for (A) normal stomach,
(B) H. pylori gastritis, (C) H. pylori-induced atrophic gastritis and (D) autoimmune atrophic gastritis. The genera were connected (Blue: positive correlation;
Red: negative correlation) when the pair-wise correlation values were significant (P.adj<0.05) after adjusting the P values for multiple comparisons.
Furthermore, subcommunity detection was performed by placing the genera in the same subcommunity (represented by colour of nodes) when many links
were found at correlation values >0.75 between members of the subcommunity. The size of the nodes represent the degree of connections.
https://doi.org/10.1371/journal.ppat.1006653.g005
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Tannerella (E. coli/Shigella/Salmonella, see supplementary methods), Treponema, and Prevotella
in the H. pylori-induced atrophic gastritis group. The vast majority of these differences remained
when H. pylori was removed from the analysis (S1 Table). Prevotellaceae were generally lower in
all patient groups compared to normal stomachs (Figs 3 and S1). As with the H. pylori gastritis
group, the majority of these changes reflected decreases in the proportions of various bacterial
genera within the H. pylori-induced atrophic gastritis group, with the only increase being in Heli-
cobacter itself.
Co-occurrence networks were more complicated in H. pylori-induced atrophic gastritis
patients compared to those subjects who had H. pylori-induced gastritis (Fig 5B & 5D). Clear
negative relationships were observed between Helicobacter and genera such as Streptococcus,
whilst Campylobacter, Prevotella, Haemophilus and Veillonella were amongst the most well-
connected and influential bacteria observed in the stomachs of H. pylori atrophic gastritis
patients (Fig 5 and S2 Table). Predicted pathway analysis showed that several pathways were
under-represented in the H. pylori-induced atrophic gastritis group, including succinate dehy-
drogenase (S3 Table). Over-represented pathways included fumarate reductase (S3 Table).
Normal stomach versus autoimmune atrophic gastritis. Streptococcaceae (38%) were
the most dominant group identified in the stomachs of patients who had autoimmune atro-
phic gastritis, followed by Prevotellaceae (9%), Flavobacteriaceae (7%), Campylobacteraceae
(7%), Enterobacteriaceae (5%) and Pasteurellaceae (5%). The stomachs of autoimmune atro-
phic gastritis patients contained a higher proportion of Streptococcaceae than all other patient
groups (Fig 3) and were the only samples that showed complete loss or gain of bacteria rather
than simply changes in bacterial proportions (Fig 4D). For example, the stomachs of autoim-
mune atrophic gastritis patients were colonised by Gemella and Bosea unlike any other patient
group. Alterations in the relative proportions of other bacteria were also found in the stomachs
of patients with autoimmune atrophic gastritis. These included increases in the proportions of
Streptococcus, Campylobacter and Haemophilus (S1 Table).
Few co-occurrence networks were identified, presumably due to the dominance of Strepto-
coccaceae, although Stenotrophomonas and Delftia; and Selenomonas and Pseudomonas
showed strong positive correlations (Fig 5D and S2 Table). Predicted pathway analysis sug-
gested that several pathways were over- or under-represented in the stomachs of patients who
had autoimmune atrophic gastritis (S3 Table).
H. pylori gastritis versus H. pylori-induced atrophic gastritis. We investigated whether
the microbiota in the stomachs of patients who had H. pylori-induced atrophic gastritis (which
were likely to be hypochlorhydric as indicated by hypergastrinaemia) differed from that in
patients who had H. pylori gastritis, normal gastric acid secretion and normogastrinaemia. No
significant differences were identified at the genus level. However, several OTUs belonging to
H. pylori were found more frequently in the H. pylori-induced atrophic gastritis group, possibly
suggesting the presence of particular strains within this group (S4 Table). Interestingly, only
two other OTUs differed in abundance between these groups, Streptococcus mitis and Neisseria
mucosa. However, these did not remain significant once H. pylori was removed from the analy-
sis. This suggests that the presence of atrophy does not result in extensive changes to bacterial
communities in the stomach relative to the simple presence of H. pylori, but may result in spe-
cific differences in individual bacterial strains.
Comparisons between the gastric microbiota of individuals with
hypochlorhydria of different aetiologies
Patients with H. pylori-induced atrophic gastritis and those receiving PPIs had similar fasting
serum gastrin concentrations (median 100pM and 140pM respectively), possibly suggesting
Comparison of the human gastric microbiota in hypochlorhydric states
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similar degrees of hypochlorhydria (although H. pylori infection may have directly contributed
to the hypergastrinaemia in the former group). In contrast patients with autoimmune atrophic
gastritis were associated with higher fasting serum gastrin concentrations (median 800pM;
Table 1). No direct association between fasting serum gastrin concentration and bacterial taxa
was observed between the different groups (PERMANOVA Unifrac P = 0.512, weighted Uni-
frac P = 0.721 and Bray-Curtis P = 0.556). This is reflected in the evidence that patients with H.
pylori-induced atrophic gastritis and those receiving PPIs exhibited marked differences in 16S
rRNA microbiota profiles, co-occurrence networks and predicted pathways, despite similar
gastrin levels. And that patients with autoimmune atrophic gastritis showed similarities to
individuals with H. pylori-induced atrophic gastritis by predicted pathway analysis, despite
markedly different serum gastrin concentrations (S3 Table).
Samples from patients with autoimmune atrophic gastritis contained significantly more
Streptococci than all other groups (Fig 3 & S1 Table). Streptococcus did not appear to be simi-
larly increased in H. pylori-induced atrophic gastritis; this may have been due to the negative
relationship observed between Helicobacter and Streptococcus identified in co-occurrence net-
works (Fig 5C).
Gastric biopsies from patients with autoimmune atrophic gastritis and those on PPIs both
showed greater bacterial diversity than was observed in the stomachs of patients with H.
pylori-induced atrophic gastritis (Fig 2). At the genus level, patients with autoimmune atrophic
gastritis showed significant increases in Tannerella, Dorea, Streptococcus, Fusobacterium and
Campylobacter compared to the patients with H. pylori-induced atrophic gastritis (S4 Table).
The stomachs of PPI-treated patients also contained significantly higher proportions of
Fusobacterium and Campylobacter than the stomachs of H. pylori-induced atrophic gastritis
patients. Furthermore, patients receiving PPI treatment showed significantly higher propor-
tions of Flavisolibacter and Dermacoccus in their stomachs than autoimmune atrophic gastritis
patients, but significantly less Paludibacter, Granulicatella, Streptococcus, and Neisseria.
Patients who had atrophic gastritis due to H. pylori or an autoimmune aetiology both
showed over-representation of several mutual pathways compared to controls (S3 Table).
However, differences between the two groups were also observed. For example, glucose-
6-phosphate 1−dehydrogenase and D−lactate dehydrogenase pathways were over-represented
in the stomachs of patients who had H. pylori-induced atrophic gastritis compared to those
who had autoimmune atrophic gastritis (S3 Table).
Discussion
Gastric samples obtained from subjects who had a normal stomach, no evidence of H. pylori
infection and normogastrinaemia had the highest levels of microbial diversity. This is consis-
tent with other reports of healthy populations showing more microbial diversity[15–17].
These samples also contained the greatest proportion of Prevotellaceae (23%) which corrobo-
rates previous research that reported normal stomachs contained 37% Prevotella, reducing to
28% in dyspeptic patients[18]. In general, the microbiota, co-occurrence networks and pre-
dicted pathways in samples from PPI-treated patients were similar to those in normal stom-
achs. This agrees with other reports that PPIs do not significantly influence the gastric
microbiota[19, 20]. At the OTU level however, samples from PPI-treated patients contained
significantly more Streptococcus. This has also been observed in gastric[20] and faecal samples
from twins discordant for PPI use[21].
H. pylori gastritis, and to some extent H. pylori-induced atrophic gastritis samples were
dominated by H. pylori. This observation may have been exacerbated by our use of RNA as
opposed to DNA for sequencing, unlike many other publications. When these two techniques
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were directly compared, H. pylori abundance was found to be 19.9 times higher in RNA com-
pared to DNA from gastric fluid samples, and was also more dominant in biopsies than gastric
fluid[19, 22]. The use of RNA ensured that only viable bacteria were included in the analysis,
giving a better indication of the taxa that are likely to be influencing the gastric environment.
H. pylori colonisation was associated with a decrease in gastric bacterial diversity, and domi-
nance of this organism, which is highly adapted to the gastric environment, has also been
reported previously[6, 23, 24].
The majority of changes observed in H. pylori gastritis and H. pylori-induced atrophic gas-
tritis samples were due to reductions in non-H. pylori bacteria. H. pylori-induced atrophic gas-
tritis samples showed complex co-occurrence networks, unlike H. pylori gastritis which
showed few connections, presumably related to the dominance of H. pylori itself in those sam-
ples. Campylobacter, Prevotella, Haemophilus and Veillonella were amongst the most influential
genera in H. pylori-induced atrophic gastritis samples. These bacteria have been previously
identified in oral and gastric samples[22].The only differences found between the two H. pylori
patient groups at the OTU level were increased abundances of specific H. pylori OTUs (possi-
bly suggesting specific bacterial strains) and increased proportions of Streptococcus mitis and
Neisseria mucosa in the atrophic group. The former species and latter genus have been identi-
fied from oral microbiota as potential biomarkers for pancreatic cancer[25]. Neisseria has been
shown to produce large amounts of alcohol dehydrogenase, which produces the carcinogen
acetaldehyde, and along with H. pylori’s high production of this enzyme, may also contribute
to gastric carcinogenesis[26]. Some strains of Streptococcaceae have previously been shown to
affect the outcomes of H. pylori infection. For example, S. mitis induces a coccoid state in H.
pylori[27] and this may lead to unsuccessful antibiotic treatment and false negative diagnostic
test results. Moreover, this coccoid form has been suggested to be more associated with gastric
adenocarcinoma development than the spiral form[28, 29].
The stomachs of patients with autoimmune atrophic gastritis (who probably had the most
profound reductions in acid secretion, as suggested by higher fasting serum gastrin concentra-
tions), showed high bacterial diversity. Samples from this group also showed significantly
higher proportions of Streptococcus than any of the other groups. They also contained Rumino-
coccus and Gemella unlike any other patient group except H. pylori-induced atrophic gastritis,
although they did not contain genera such as Arthrobacter, Cupriavidus and Sneathia. There-
fore, bacterial communities were both lost and gained in this condition. Co-occurrence net-
works appeared to be disrupted by the overabundance of Streptococcaceae resulting in few
connections.
The microbial profiles in the stomachs of patients with H. pylori-induced atrophic gastritis
and autoimmune atrophic gastritis were quite different. In addition, pathways such as glucose-
6-phosphate 1−dehydrogenase and D−lactate dehydrogenase were over-represented in the
stomachs of patients with H. pylori-induced atrophic gastritis compared to autoimmune atro-
phic gastritis. Overexpression of these pathways has been associated with poorer prognoses in
gastric cancer[30, 31]. Conversely, several other metabolic pathways such as fumarate reduc-
tase were increased in representation in patients with both autoimmune and H. pylori associ-
ated atrophic gastritis. Fumarate reductase is involved in the metabolism of some bacteria
and is essential for colonisation by H. pylori in the mouse stomach[32–34]. Interestingly, succi-
nate dehydrogenase (which has an opposite action to fumarate reductase) was found to be
decreased in both atrophic gastritis groups compared to both the normal and PPI-treated sam-
ples. Lower levels of succinate dehydrogenase have previously been found in gastrointestinal
tumours and parietal cells[35, 36]. PPI-treated patients showed more similarities in microbial
diversity and abundance to the patients who had autoimmune atrophic gastritis, than to the
patients who had H. pylori-induced atrophic gastritis.
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The strengths of this study are the relatively large cohort of patients and the subsequently
high numbers of samples sequenced. Weaknesses of the study include a lack of dietary infor-
mation recorded for the patients, and although patient groups had similar age and gender pro-
files it was not possible to specifically age/gender match them as priority was given to the strict
criteria used to allocate patients to groups. Future studies are also needed to elucidate and con-
firm the predicted pathway analysis.
Conclusion
Our findings indicate that H. pylori colonisation and hypochlorhydria (other than that which
was caused by PPI treatment) result in changes in gastric bacterial abundance and only rarely
in loss/gain of bacteria. PPI treatment did not significantly alter the gastric microbiota from
that of a normal stomach, despite serum gastrin concentrations being comparable to those
found in patients with H. pylori-induced atrophic gastritis. Microbial patterns were not found
to correlate with gastrin levels, although it should be noted that factors including H. pylori
infection status may have confounded this relationship. Autoimmune atrophic gastritis
resulted in a different, more diverse microbial pattern than that observed in the stomachs of
patients who had H. pylori-induced atrophic gastritis. This may be due to differences in acid
secretion between these conditions or other factors such as different immune profiles. Several
biochemical pathways were represented in similar fashions in both atrophic gastritis groups.
In particular, gastric-atrophy was associated with changes in the citric acid cycle (biochemical
pathway that is known to be associated with gastric carcinogenesis) and our findings suggest
that the microbiota may be an important contributor to this. The development of gastric can-
cer is multifactorial, and data from the present study suggest that the non-H. pylori microbiota
may be a participating factor.
Materials and methods
Ethics
Acquisition of the biopsies used in this study was approved by Liverpool (08/H1005/37) and
Cambridge East (10/H0304/51) Research Ethics Committees as previously described[37, 38].
All patients gave written informed consent.
Patients
One hundred gastric biopsy samples in 5 different groups were selected from a cohort of 1400
prospectively recruited patients who underwent diagnostic upper gastrointestinal endoscopy
at Royal Liverpool University Hospital[37] and from 8 patients with type I gastric NETs who
had been recruited to a clinical trial[38, 39] (Table 1). The patients in the 1400 cohort had the
following characteristics: Females 57.5%, median age 60 years with an interquartile range 48–
70 years and 98.4% were Caucasian. Overall more than half the cohort (52.3%) reported PPI
use, 21.8% were positive for H. pylori infection by histology, and 43.3% were positive by serol-
ogy. Patients were selected from this cohort according to the criteria described below and that
are outlined in Table 1. None of the selected patients were taking PPIs, except those in the PPI
treated group. In some patient groups (e.g. those with H. pylori associated atrophy and autoim-
mune atrophic gastritis) all samples which matched the inclusion criteria were sequenced, but
for other groups (e.g. normal and PPI treated groups), subjects were chosen for inclusion
based on the availability of tissue (as biopsy samples from this cohort have also been used for
other studies).
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Patients in the normal stomach group had a normal endoscopy, no evidence of H. pylori
infection by histology, rapid urease test or serology, were not taking a PPI and were normo-
gastrinaemic. Patients belonging to the H. pylori gastritis group were positive for H. pylori
by rapid urease test, histology and serology, had no histological evidence of atrophic gastri-
tis, were not taking a PPI and were normogastrinaemic. Patients in the H. pylori-induced
atrophic gastritis group showed histological evidence of corpus atrophic gastritis and/or
intestinal metaplasia, had no dysplasia or cancer, were positive for H. pylori by serology,
were not taking a PPI and were hypergastrinaemic. Six out of the 23 patients in this group
were also H. pylori positive by urease test and/or histology. Details of histological Sydney
scoring [40] can be seen in S4 Fig. Patients in both H. pylori infected groups showed higher
scores in both antrum and corpus than patients in the normal stomach and PPI treated
groups. Patients in the autoimmune atrophic gastritis group had histological evidence of
atrophic gastritis, no evidence of H. pylori infection by rapid urease test or histology, posi-
tive anti-gastric parietal cell and/or intrinsic factor antibodies, were markedly hypergastri-
naemic and 8 out of 11 also had grade 1 type I gastric NETs. Patients in the PPI-treated
group were currently taking PPIs, had no evidence of H. pylori infection by serology, rapid
urease test or histology, had no histological evidence of atrophic gastritis and were hyper-
gastrinaemic (suggesting significant hypochlorhydria).
Samples
At least two biopsies per site were obtained from the gastric antrum and corpus for histopa-
thology. Eight additional corpus biopsies were stored in RNA later immediately after removal
and were extracted using a modified Tri- reagent protocol[41]. Briefly, samples were thawed
and separated from RNA later, before being homogenised in Tri-Reagent (Sigma-Aldrich, Gil-
lingham, UK). Chloroform was added and the resulting clear aqueous layer was combined
with isopropanol before centrifugation to produce a precipitated RNA pellet. This was washed
with 75% and 100% ice cold ethanol before being allowed to dry and then resuspended in
diethylpyrocarbonate (DEPC)-treated water (Sigma-Aldrich, Gillingham, UK). RNA was
stored in ethanol at -80˚C. Ethanol was removed and pellets were resuspended in DEPC-water
prior to reverse transcription.
Gastrin assays
Serum gastrin concentrations were measured by radioimmunoassay (RIA) as previously
described[42, 43]. Fasting serum gastrin concentrations were all<40pM in normogastrinae-
mic subjects and>40pM (with the majority >100pM) in hypergastrinaemic subjects.
Reverse transcription
Samples and random primers were denatured together for 5 minutes at 65˚C before Proto
reaction mix and Proto enzyme from a ProtoScript II First Strand cDNA Synthesis kit (NEB,
E6560L) were added. Samples were then incubated at 25˚C for 5 minutes, 42˚C for 20 minutes,
and 80˚C for 5 minutes. Newly synthesised cDNA was then measured using a Qubit high sen-
sitivity assay (ThermoFisher Ltd, Paisley, UK).
16S rRNA sequencing
The 16S rRNA gene was targeted using V1-V2 (27F and 388R) primers[44] with slight modifi-
cations: forward primer 5’ACACTCTTTCCCTACACGACGC TCTTCCGATCTNNNNNA
GAGTTTGATCMTGGCTCAG’3, reverse primer 5’GTGACTGGAGTTCAGACGTGTGCT
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CTTCCGATCTGCTGCCTCCCGTAGGAGT’3. Primers were validated using a mock com-
munity described in supplementary methods. The following cycling conditions were used: ini-
tial denaturation 94˚C for 5 minutes, followed by 10 cycles of denaturation at 98˚C for 20
seconds, annealing at 60˚C for 15 seconds, and elongation at 72˚C for 15 seconds, followed by
a final elongation step of 72˚C for 1 minute. PCR amplicons were purified to remove excess
primers, nucleotides, salts, and enzymes using the Agencourt AMPure XP system (Beckman
Coulter Ltd, High Wycombe, UK). Purified amplicons were used in a second PCR reaction
with the same conditions except with 20 cycles. This second step was used to add dual index
barcodes. The PCR amplicons were purified as above. All PCR reactions used Kapa HiFi Hot-
StartStart 2× master mix (Anachem Ltd, Bedfordshire, UK) and all primers were used at
10μM. Amplicon sizes were checked using a fragment analyser (Advanced Analytical, Ankeny,
USA) and size selection was performed using a Pippin prep (Sage Science, Beverly, USA). The
quantity and quality of the samples in the final libraries were checked using a SYBR Green
qPCR assay and the Illumina Library Quantification kit (Kapa) on a Roche Light Cycler
LC480II, according to the manufacturer’s instructions.
Prior to loading samples onto the MiSeq, PhiX was added (10–15%) to increase diversity,
and samples were then denatured with NaOH according to the Illumina MiSeq protocol.
ssDNA library fragments were diluted to a final concentration of 8pM. 600μl of ssDNA library
was loaded into a MiSeq Reagent Cartridge and a 500–cycle PE kit v2 was used. Paired-end
sequencing was performed according to the manufacturer’s instructions (Illumina, SanDiego,
CA, USA). Sequence analysis methodology is described in the supplementary methods. Reads
were submitted to EBI short-read archive accession-PRJEB21104.
Statistical analysis
Details are described in the supplementary methods (S1 Text).
Supporting information
S1 Text. Includes complete details of the structure of mock bacterial communities, and
sequencing and statistical methods.
(DOCX)
S1 Fig. Relative abundances of taxa found within human gastric biopsies after removal of
Helicobacteraceae. Hp = H. pylori, IM = intestinal metaplasia, IM+At = intestinal metaplasia
and atrophy, PPI = proton pump inhibitor. All H. pylori atrophy samples were positive for H.
pylori by serology.
(PDF)
S2 Fig. Significantly different OTUs identified between normal stomach samples and PPI.
The most significant OTUs are identified on the left. Differential expression analysis based on
the Negative Binomial (Gamma-Poisson) distribution.
(PDF)
S3 Fig. Co-occurrence network analysis between different genera (OTUs collated together at
genus level) when considering samples for (A) PPI. The genera were connected (Blue: positive
correlation; Red: negative correlation) when the pair-wise correlation values were significant
(P.adj<0.05) after adjusting the P values for multiple comparisons. Furthermore, subcommu-
nity detection was performed by placing the genera in the same subcommunity (represented
by colour of nodes) when many links were found at correlation values >0.75 between mem-
bers of the subcommunity. The size of the nodes represent the degree of connections (B) net-
work-wide statistics by degree, closeness, betweenness and eigenvalue centrality for H. pylori
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atrophic gastritis cases. The nodes (coloured with respect to subcommunity they are part of)
were placed on concentric circles with values increasing from center to the periphery. A high
betweenness for a node suggests many connections, whereas a high eigenvalue centrality sug-
gests that those connections, in turn, are all well connected. On average a high betweenness
and at the same time low eigenvalue centrality for a subcommunity suggests a keystone/impor-
tant subcommunity.
(PDF)
S4 Fig. Mean updated Sydney scores in antrum and corpus. Updated Sydney scores were the
sum of the scores for 5 individual parameters each scored 0–3 [40].  p<0.0001 versus con-
trol from the same mucosal site by 2-way ANOVA using Dunnett’s multiple comparison test.
(PDF)
S1 Table. Significantly different genera identified between normal stomach samples and
PPI, autoimmune atrophic gastritis, H. pylori-induced atrophic gastritis and H. pylori gas-
tritis. The most significant species are identified at the top. Differential expression analysis
based on the Negative Binomial (Gamma-Poisson) distribution and were corrected for multi-
ple comparisons.  indicates a genus no longer significant when H. pylori was removed from
the analysis.
(DOCX)
S2 Table. (A)Stable bacterial populations and correlations in PPI patients compared to other
groups (if the correlation between two genera were consistently positive or negative in differ-
ent groups). PPI versus H. pylori-induced atrophic gastritis in table S2B. No significant com-
parisons were found between PPI and autoimmune atrophic gastritis groups. (B) Stable
bacterial populations and correlations in H. pylori-induced atrophic gastritis patients com-
pared to other groups.
(DOCX)
S3 Table. The top most significant predicted pathways found for each group comparison.
(DOCX)
S4 Table. (A) Significant bacterial species identified between H. pylori atrophic gastritis and
H. pylori gastritis. The most significant species are identified at the top. Differential expression
analysis based on the Negative Binomial (Gamma-Poisson) distribution. Streptococcus identi-
fied by BLAST as S. mitis with 98% coverage, 99% identity and Neisseria mucosa had 98% cov-
erage and 100% identity. None of these OTUs remained significant when H. pylori was
removed from the analysis. (B) Significant bacterial genera identified between autoimmune
atrophic gastritis and H. pylori-induced atrophic gastritis. The most significant species are
identified at the top. Differential expression analysis based on the Negative Binomial (Gamma-
Poisson) distribution. NB when H. pylori was removed from the analysis these genera
remained significant, with an additional genus Desulfobulbus also reaching significance.
(DOCX)
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